Home › Funds › 683 Capital Management, LLC › TRAX

683 Capital Management, LLC position in TRAX

FIRST TRACKS BIOTHERAPEUTICS · Health Care

683 Capital Management, LLC reported holding 600,000 shares of TRAX (FIRST TRACKS BIOTHERAPEUTICS) in its Q3 2026 13F filing — a position valued at US$21.3M, representing 0.94% of its reported portfolio and ranking #22 among its reported holdings. 683 Capital Management, LLC has disclosed TRAX holdings in 2 of the last 2 reported quarters, going back to Q2 2026.

Latest position (Q3 2026)600.00K sh
Reported value held$21.26M
Portfolio Weight0.94%
First reportedQ2 2026
Last changeReduce
Updated2026-11-16

Last updated: 2026-11-16 · Source: SEC EDGAR Form 13F-HR

How 683 Capital Management, LLC's TRAX position evolved

683 Capital Management, LLC first disclosed a stake in TRAX in Q2 2026 at 750,000 shares (US$15.1M). The position peaked in Q3 2026 at 600,000 shares, worth US$21.3M. Across 2 filings, 683 Capital Management, LLC increased the stake 0 time(s), trimmed it 1 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 600,000 shares valued at US$21.3M — a reduction of -150,000 shares quarter over quarter..

Quarter by quarter

QuarterSharesValueChange
Q2 2026 750.00K $15.09M New
Q3 2026 600.00K $21.26M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About TRAX and 13F data

TRAX (FIRST TRACKS BIOTHERAPEUTICS) is a Health Care company. 181 other funds we track also report a position in TRAX — the largest reported positions include EcoR1 Capital, LLC (US$112.5M), TCG Crossover Management, LLC (US$102.6M), Affinity Asset Advisors, LLC (US$73.7M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding TRAX

All TRAX fund holders →

FAQ

How long has 683 Capital Management, LLC held TRAX?

683 Capital Management, LLC has disclosed TRAX holdings in 2 of the last 2 reported quarters, going back to Q2 2026.

What is 683 Capital Management, LLC's current position in TRAX?

As of Q3 2026, 683 Capital Management, LLC holds 600.00K shares of TRAX (FIRST TRACKS BIOTHERAPEUTICS), valued at $21.26M, representing 0.94% of its reported portfolio and ranking #22.

Has 683 Capital Management, LLC been buying or selling TRAX?

In the latest 13F filing (Q3 2026), 683 Capital Management, LLC reduced its position in TRAX. The position peaked in Q3 2026 at 600.00K shares.

Which other funds hold TRAX?

Other major institutional holders of TRAX include EcoR1 Capital, LLC, TCG Crossover Management, LLC, Affinity Asset Advisors, LLC, among 181 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.